Skip to Content

Gabapentin Enacarbil

In the US, Gabapentin Enacarbil (gabapentin enacarbil systemic) is a member of the drug class gamma-aminobutyric acid analogs and is used to treat Alcoholism, Postherpetic Neuralgia and Restless Legs Syndrome.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiepileptic agent

Chemical Name

(1-{[({(1RS)-1-[(2-metylpropanoyl)oxy]etoxy}carbonyl)amino]metyl}cyclohexyl)acetic acid (WHO)

Foreign Names

  • Gabapentinum enacarbilum (Latin)
  • Gabapentin enacarbil (German)
  • Gabapentine enacarbil (French)
  • Gabapentina enacarbilo (Spanish)

Generic Names

  • Gabapentin Enacarbil (OS: USAN, JAN)
  • GSK 1838262 (IS)
  • Solzira (IS)
  • XP13512 (IS)

Brand Names


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.